Estradiol Structrual Formula (Image 01)
Estradiol Patch
Product Images NDC 0378-4641
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 0378-4641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Transdermal Patch Cross Section (Image 02)
Figure 01 (Image 03)
The given text seems to be a graph presenting the steady-state Estradiol Plasma Concentrations for Systems applied to the abdomen. The concentrations are measured in pg/mL and plotted against time in days. The text also includes the dosages used for each system, in mocay and moiday units.*
Figure 02 (Image 04)
Figure 03 (Image 05)
Figure 04 (Image 06)
Instructions For Use Figure 01 (Image 07)
Instructions For Use Figure 02 (Image 08)
Instructions For Use Figure 03 (Image 09)
Instructions For Use Figure 04 (Image 10)
Instructions For Use Figure 05 (Image 11)
Instructions For Use Figure 06 (Image 12)
Instructions For Use Figure 07 (Image 13)
Instructions For Use Figure 08 (Image 14)
Instructions For Use Figure 09 (Image 15)
Instructions For Use Figure 10 (Image 16)
Estradiol Transdermal System 0.025 mg/day (twice-weekly) Carton Label (Image 17)
This is a product description of a medicated patch that delivers 0.025mg/day of estradiol. The formulation includes various active and inactive components such as estradiol, silicone adhesive, acrylic adhesive, dipropylene glycol, povidone, oleyl alcohol, polyolefin backing film, and polyester release liner. The patch should be applied immediately after removing from its pouch, and not stored unpouched. The usual dosage is not provided. This particular patch is made by Mylan Pharmaceuticals, and it should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F).*
Estradiol Transdermal System 0.0375 mg/day (twice-weekly) Carton Label (Image 18)
This is a description of a medical product. The product name is not clear from the text. It contains 0.62 mg estradiol and is used to deliver 0.0375mg/day. The system size is 3.75cm² and its components include silicone adhesive, acrylic adhesive, dipropylene glycol, povidone, oleyl alcohol, Polyolefin backing film, and Polyester release liner. The product should be applied immediately once removed from the pouch and should not be stored unpouched. The usual dosage instructions can be found on the prescribing information. The product is manufactured by Mylan Pharmaceuticals Inc and it should be stored at 20° to 25°C.*
Estradiol Transdermal System 0.05 mg/day (twice-weekly) Carton Label (Image 19)
Delivers 0.05 mg/day of estradiol using a transdermal patch system. Apply the patch immediately upon removal from the pouch and don't store unpouched. Each 5.0 cm2 system contains 0.82 mg of estradiol USP hemihydrate. The patch contains silicone adhesive, acrylic adhesive, dipropylene glycol, povidone, oleyl alcohol, polyolefin backing film, and polyester release liner. The patch should be stored at 20° to 25°C. For more information, refer to the prescribing information.*
Estradiol Transdermal System 0.075 mg/day (twice-weekly) Carton Label (Image 20)
This is a pharmaceutical product description. The medication contains 0.075 mg/day of estradiol, USP hemihydrate and is delivered through a 7.5 cm² system. The inactive ingredients are silicone adhesive, acrylic adhesive, dipropylene glycol, povidone, oleyl alcohol, polyolefin backing film, and polyester release liner. The device should be applied immediately after opening as it should not be stored unopened. The medication should also be stored between 20°C to 25°C. The prescription information should be consulted by users to determine the correct dosage. The manufacturer is listed as Mylan Pharmaceuticals Inc. with a location of Morgantown, W 26505 US.A. There is irrelevant and unreadable text as well as a marking for "No Copy."*
Estradiol Transdermal System 0.1 mg/day (twice-weekly) Carton Label (Image 21)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
